|
Volumn 80, Issue 2, 2013, Pages 254-256
|
Anti-tau antibodies: Hitting the target
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY HJ3.4;
MONOCLONAL ANTIBODY HJ8.5;
MONOCLONAL ANTIBODY HJ8.7;
MONOCLONAL ANTIBODY HJ9.3;
MONOCLONAL ANTIBODY HJ9.4;
PROTEIN ANTIBODY;
TAU PROTEIN;
TAU PROTEIN ANTIBODY;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
COGNITIVE DEFECT;
CONTROLLED STUDY;
DRUG MECHANISM;
EXTRACELLULAR MATRIX;
HUMAN;
HUMAN CELL;
IMMUNOTHERAPY;
IN VITRO STUDY;
IN VIVO STUDY;
LATERAL BRAIN VENTRICLE;
MICROGLIA;
MOUSE;
NERVE CELL STIMULATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN AGGREGATION;
PROTEIN PHOSPHORYLATION;
SHORT SURVEY;
TAUOPATHY;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BRAIN;
COGNITION DISORDERS;
HUMANS;
TAU PROTEINS;
TAUOPATHIES;
|
EID: 84885745164
PISSN: 08966273
EISSN: 10974199
Source Type: Journal
DOI: 10.1016/j.neuron.2013.10.009 Document Type: Short Survey |
Times cited : (16)
|
References (15)
|